Influence of brachytherapy applicators geometry on dose distribution in cervical cancer
Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess r...
Saved in:
Published in: | Strahlentherapie und Onkologie Vol. 173; no. 6; pp. 323 - 329 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
München
Springer
01-06-1997
Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess retrospectively the influence of the size of cervical cancer brachytherapy applicators (ovoids and uterine tandems) on pelvic dose distribution and the impact of various therapy-dependent factors on patient anatomy and on dose distribution in particular applications.
The subject of this study were 356 cervical cancer patients treated with Selectron LDR as a part of their radical radiotherapy. Analysed factors included preceding external beam radiotherapy (EBRT) or brachytherapy applications, use of general anaesthesia for application and the system of pellet loading.
Significant correlation was found between the size of applicators and doses to bladder, rectum and points B: larger vaginal applicators produced lower dose in bladder and rectum and higher dose in point B (all p < 0.0001), longer uterine tandems produced lower dose in rectum and higher dose in point B (both p < 0.0001). Significant decrease in the frequency of use of large applicators (ovoids: p < 0.0001, tandems: p = 0.055) and worsening of dose distribution, i.e. higher doses to critical organs (respectively: bladder p = 0.0012, rectum p = 0.02) and lower point B dose (p = 0.0001) were observed at consecutive brachytherapy applications. Similar situation occurred in patients, who received EBRT prior to brachytherapy (ovoids: p < 0.001, tandem: p = 0.04, bladder dose: p = 0.009, rectal dose: p = 0.073, point B dose: p = 0.059). Vaginal applicators were larger (p = 0.026) and the dose distribution was better (bladder: p = 0.023, rectum: p = 0.002, point B: p = 0.0001) in patients who had their insertions performed under general anaesthesia. The comparison of 2 consecutively used systems of pellet loading revealed more favourable dose distribution: lower dose for bladder (p = 0.014) and higher dose for point B (p < 0.0001) for the system, which utilised more sources in ovoids and in the distal part of the uterine tandem, in spite of more frequent use of smaller applicators in this group of patients. In multivariate analysis ovoid size was related to preceding external beam radiotherapy (p = 0.025). Uterine tandem length was dependent on the number of preceding intracavitary applications (p < 0.001) and preceding external beam radiotherapy (p = 0.007). Bladder dose was related to preceding brachytherapy (p = 0.011) and the pattern of pellet loading (p = 0.031). Rectal dose was dependent only on the use of general anaesthesia during application (p = 0.001) and point B dose was dependent on the pattern of pellet loading (p < 0.001) and marginally-on the use of preceding external beam radiotherapy (p = 0.06).
The results of this study allow for identification of treatment-related factors determining pelvic dose distribution in cervical cancer brachytherapy and may potentially enable optimisation of this distribution in particular clinical situation. |
---|---|
AbstractList | AimAlthough the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess retrospectively the influence of the size of cervical cancer brachytherapy applicators (ovoids and uterine tandems) on pelvic dose distribution and the impact of various therapy-dependent factors on patient anatomy and on dose distribution in particular applications.Patients and MethodThe subject of this study were 356 cervical cancer patients treated with Selectron LDR as a part of their radical radiotherapy. Analysed factors included preceding external beam radiotherapy (EBRT) or brachytherapy applications, use of general anaesthesia for application and the system of pellet loading.ResultsSignificant correlation was found between the size of applicators and doses to bladder, rectum and points B: larger vaginal applicators produced lower dose in bladder and rectum and higher dose in point B (all p<0.0001), longer uterine tandems produced lower dose in rectum and higher dose in point B (both p<0.0001). Significant decrease in the frequency of use of large applicators (ovoids: p<0.0001, tandems: p=0.055) and worsening of dose distribution, i.e. higher doses to critical organs (respectively: bladder p=0.0012, rectum p=0.02) and lower point B dose (p=0.0001) were observed at consecutive brachytherapy applications. Similar situation occurred in patients, who received EBRT prior to brachytherapy (ovoids: p<0.001, tandem: p=0.04, bladder dose: p=0.009, rectal dose: p=0.073, point B dose: p=0.059). Vaginal applicators were larger (p=0.026) and the dose distribution was better (bladder: p=0.023, rectum: p=0.002, point B: p=0.0001) in patients who had their insertions performed under general anaesthesia. The comparison of 2 consecutively used systems of pellet loading revealed more favourable dose distribution: lower dose for bladder (p=0.014) and higher dose for point B (p<0.0001) for the system, which utilised more sources in ovoids and in the distal part of the uterine tandem, in spite of more frequent use of smaller applicators in this group of patients. In multivariate analysis ovoid size was related to preceding external beam radiotherapy (p=0.025). Uterine tandem length was dependent on the number of preceding intracavitary applications (p<0.001) and preceding external beam radiotherapy (p=0.007). Bladder dose was related to preceding brachytherapy (p=0.011) and the pattern of pellet loading (p=0.031). Rectal dose was dependent only on the use of general anaesthesia during application (p=0.001) and point B dose was dependent on the pattern of pellet loading (p<0.001) and marginally — on the use of preceding external beam radiotherapy (p=0.06).ConclusionsThe results of this study allow for identification of treatment-related factors determining pelvic dose distribution in cervical cancer brachytherapy and may potentially enable optimisation of this distribution in particular clinical situation. Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess retrospectively the influence of the size of cervical cancer brachytherapy applicators (ovoids and uterine tandems) on pelvic dose distribution and the impact of various therapy-dependent factors on patient anatomy and on dose distribution in particular applications. The subject of this study were 356 cervical cancer patients treated with Selectron LDR as a part of their radical radiotherapy. Analysed factors included preceding external beam radiotherapy (EBRT) or brachytherapy applications, use of general anaesthesia for application and the system of pellet loading. Significant correlation was found between the size of applicators and doses to bladder, rectum and points B: larger vaginal applicators produced lower dose in bladder and rectum and higher dose in point B (all p < 0.0001), longer uterine tandems produced lower dose in rectum and higher dose in point B (both p < 0.0001). Significant decrease in the frequency of use of large applicators (ovoids: p < 0.0001, tandems: p = 0.055) and worsening of dose distribution, i.e. higher doses to critical organs (respectively: bladder p = 0.0012, rectum p = 0.02) and lower point B dose (p = 0.0001) were observed at consecutive brachytherapy applications. Similar situation occurred in patients, who received EBRT prior to brachytherapy (ovoids: p < 0.001, tandem: p = 0.04, bladder dose: p = 0.009, rectal dose: p = 0.073, point B dose: p = 0.059). Vaginal applicators were larger (p = 0.026) and the dose distribution was better (bladder: p = 0.023, rectum: p = 0.002, point B: p = 0.0001) in patients who had their insertions performed under general anaesthesia. The comparison of 2 consecutively used systems of pellet loading revealed more favourable dose distribution: lower dose for bladder (p = 0.014) and higher dose for point B (p < 0.0001) for the system, which utilised more sources in ovoids and in the distal part of the uterine tandem, in spite of more frequent use of smaller applicators in this group of patients. In multivariate analysis ovoid size was related to preceding external beam radiotherapy (p = 0.025). Uterine tandem length was dependent on the number of preceding intracavitary applications (p < 0.001) and preceding external beam radiotherapy (p = 0.007). Bladder dose was related to preceding brachytherapy (p = 0.011) and the pattern of pellet loading (p = 0.031). Rectal dose was dependent only on the use of general anaesthesia during application (p = 0.001) and point B dose was dependent on the pattern of pellet loading (p < 0.001) and marginally-on the use of preceding external beam radiotherapy (p = 0.06). The results of this study allow for identification of treatment-related factors determining pelvic dose distribution in cervical cancer brachytherapy and may potentially enable optimisation of this distribution in particular clinical situation. |
ArticleNumber | 323 |
Author | SERKIES, K SENKUS-KONEFKA, E BADZIO, A JASSEM, J KOBIERSKA, A |
Author_xml | – sequence: 1 givenname: E surname: SENKUS-KONEFKA fullname: SENKUS-KONEFKA, E organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland – sequence: 2 givenname: A surname: KOBIERSKA fullname: KOBIERSKA, A organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland – sequence: 3 givenname: J surname: JASSEM fullname: JASSEM, J organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland – sequence: 4 givenname: K surname: SERKIES fullname: SERKIES, K organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland – sequence: 5 givenname: A surname: BADZIO fullname: BADZIO, A organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2701826$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9209530$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkEFLHTEUhUOx6NN2030hiLgQxt6bTCbJshW1gtCNpd0NecmdOjJvMiYzhffvjfhQcHXhnI_D5Ttke2McibEvCOcIoL_9uAIJ0lhUH9gKa2krsPbvHlsBaltpVOaAHeb8AIBNbet9tm8FWCVhxf7cjN2w0OiJx46vk_P32_mekpu23E3T0Hs3x5T5P4obmtOWx5GHmImHPs-pXy9zX5J-5J7S_wIP3Lsylj6xj50bMn3e3SP2--ry7uJndfvr-ubi-23lhZJzJZXwNToTpAmd9nVnkRpvQKkATnqLUoMQRNIZrUODqoSGDIagTON9I4_Y6cvulOLjQnluN332NAxupLjkVltEoZUt4PE78CEuaSy_tUagbiTWUKCzF8inmHOirp1Sv3Fp2yK0z6rbN9UF_rpbXNYbCq_ozm3pT3a9y0VMl4qYPr9iQgMa0cgnWMeHDg |
CODEN | STONE4 |
CitedBy_id | crossref_primary_10_1016_j_ijrobp_2003_09_090 crossref_primary_10_1017_S1460396924000074 crossref_primary_10_1016_j_meddos_2013_06_001 crossref_primary_10_1016_j_brachy_2009_08_014 crossref_primary_10_1120_jacmp_v17i3_5536 crossref_primary_10_1097_00001703_199810000_00011 crossref_primary_10_1120_jacmp_v17i3_5584 |
Cites_doi | 10.1259/0007-1285-49-581-430 10.1016/0090-8258(76)90034-2 10.1016/0360-3016(90)90424-I 10.1016/0360-3016(89)90015-1 10.1259/0007-1285-26-305-252 10.1016/0360-3016(90)90329-I 10.1002/1097-0142(19810715)48:1+<538::AID-CNCR2820481317>3.0.CO;2-P 10.1016/S0002-9378(16)34236-3 10.1016/0167-8140(94)91126-6 10.1016/0360-3016(93)90022-N 10.1016/0360-3016(87)90041-1 10.1016/0360-3016(83)90298-5 10.1148/86.5.921 10.1016/0090-8258(88)90140-0 10.1259/0007-1285-56-666-409 10.1016/0360-3016(82)90446-1 10.1259/0007-1285-60-713-481 10.1259/0007-1285-62-736-362 10.1016/0360-3016(81)90150-4 10.1016/S0009-9260(85)80095-7 10.1016/0360-3016(86)90413-X 10.1016/0360-3016(81)90381-3 10.1016/0360-3016(93)90402-H 10.1016/S0167-8140(87)80182-2 10.1016/0360-3016(87)90193-3 |
ContentType | Journal Article |
Copyright | 1997 INIST-CNRS Urban & Vogel 1997. |
Copyright_xml | – notice: 1997 INIST-CNRS – notice: Urban & Vogel 1997. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7X7 7XB 88E 8AO 8C1 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. KB0 M0S M1P NAPCQ P5Z P62 PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/BF03038915 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals Health Medical collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Aerospace Database (1962 - current) ProQuest Central Technology Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Technology Collection ProQuest Advanced Technologies & Aerospace Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Technology Collection MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1439-099X |
EndPage | 329 |
ExternalDocumentID | 2226114921 10_1007_BF03038915 9209530 2701826 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 04C 06C 06D 0R~ 0VY 123 1N0 1SB 203 29Q 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5RE 5VS 67Z 6NX 7RV 7X7 88E 8AO 8C1 8FE 8FG 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABQG AAFGU AAHNG AAIAL AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAWTL AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJOX ABKAS ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGLVJ BGNMA BKEYQ BMSDO BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIHBH EIOEI EJD EN4 ESBYG EX3 FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMJXF HQYDN HRMNR HZ~ IHE IJ- IKXTQ IMOTQ IQODW IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P62 P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R89 R9I RIG ROL RPX RRX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW X7J YLTOR Z45 Z7U Z87 ZMTXR ZOVNA ZXP AACDK AAJBT AASML AAYZH ABAKF ABJNI ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU ALIPV CGR CUY CVF ECM EIF EMB EMOBN HMCUK HVGLF NPM SV3 AAYXX CITATION 7XB 8FK DWQXO K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c253t-352c41a8d38df7c4f91e6c8055d0a3c9137022ee3a877d615a3c8e81dd586cc63 |
ISSN | 0179-7158 |
IngestDate | Fri Oct 25 05:46:39 EDT 2024 Mon Nov 04 10:36:54 EST 2024 Thu Nov 21 20:57:05 EST 2024 Wed Oct 16 00:41:23 EDT 2024 Sun Oct 29 17:08:02 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Dose repartition Human Position Size Uterine cervix Dimension Malignant tumor Radiotherapy Female genital diseases Geometry Radiation dose Applicator Treatment Pelvic cavity Female Technique Curietherapy Uterine cervix diseases |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c253t-352c41a8d38df7c4f91e6c8055d0a3c9137022ee3a877d615a3c8e81dd586cc63 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 9209530 |
PQID | 821763140 |
PQPubID | 54006 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_79112759 proquest_journals_821763140 crossref_primary_10_1007_BF03038915 pubmed_primary_9209530 pascalfrancis_primary_2701826 |
PublicationCentury | 1900 |
PublicationDate | 1997-Jun |
PublicationDateYYYYMMDD | 1997-06-01 |
PublicationDate_xml | – month: 06 year: 1997 text: 1997-Jun |
PublicationDecade | 1990 |
PublicationPlace | München |
PublicationPlace_xml | – name: München – name: Germany – name: Heidelberg |
PublicationTitle | Strahlentherapie und Onkologie |
PublicationTitleAlternate | Strahlenther Onkol |
PublicationYear | 1997 |
Publisher | Springer Springer Nature B.V |
Publisher_xml | – name: Springer – name: Springer Nature B.V |
References | L. Krishnan (BF03038915_CR13) 1990; 18 G. S. Montana (BF03038915_CR16) 1989; 16 A. Arican (BF03038915_CR1) 1994; 31 B. M. Peckham (BF03038915_CR18) 1969; 104 H. Pourquier (BF03038915_CR22) 1982; 8 M. Tod (BF03038915_CR26) 1953; 26 T. Teschima (BF03038915_CR25) 1985; 161 D. A. Jones (BF03038915_CR11) 1987; 60 B. Corn (BF03038915_CR2) 1991; 21 R. A. Potish (BF03038915_CR20) 1990; 18 B. A. Esche (BF03038915_CR6) 1987; 13 J. M. Wilkinson (BF03038915_CR29) 1983; 56 A. Górny (BF03038915_CR7) 1992; 63 A. Eisbruch (BF03038915_CR5) 1990; 25 J. M. Crook (BF03038915_CR3) 1987; 8 K. H. Lee (BF03038915_CR14) 1976; 49 C. G. Orton (BF03038915_CR17) 1986; 12 A. D. Hamberger (BF03038915_CR9) 1983; 9 P. W. Grigsby (BF03038915_CR8) 1993; 27 R. R. Million (BF03038915_CR15) 1966; 60 ICRU Report 38 (BF03038915_CR10) 1985 E. Sherrah-Davies (BF03038915_CR23) 1985; 36 H. Pourquier (BF03038915_CR21) 1997; 13 C. C. Wang (BF03038915_CR28) 1981; 48 J. M. Wilkinson (BF03038915_CR30) 1989; 62 D. E. Cunningham (BF03038915_CR4) 1981; 7 J. A. Stryker (BF03038915_CR24) 1988; 29 A. Unal (BF03038915_CR27) 1981; 7 (BF03038915_CR19) 1990 A. R. Kagan (BF03038915_CR12) 1976; 4 |
References_xml | – volume: 49 start-page: 430 year: 1976 ident: BF03038915_CR14 publication-title: Brit. J. Radiol. doi: 10.1259/0007-1285-49-581-430 contributor: fullname: K. H. Lee – volume: 4 start-page: 291 year: 1976 ident: BF03038915_CR12 publication-title: Gynec. Oncol. doi: 10.1016/0090-8258(76)90034-2 contributor: fullname: A. R. Kagan – volume: 18 start-page: 965 year: 1990 ident: BF03038915_CR13 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(90)90424-I contributor: fullname: L. Krishnan – volume: 16 start-page: 95 year: 1989 ident: BF03038915_CR16 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(89)90015-1 contributor: fullname: G. S. Montana – volume: 26 start-page: 252 year: 1953 ident: BF03038915_CR26 publication-title: Brit. J. Radiol. doi: 10.1259/0007-1285-26-305-252 contributor: fullname: M. Tod – volume: 18 start-page: 1513 year: 1990 ident: BF03038915_CR20 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(90)90329-I contributor: fullname: R. A. Potish – volume: 48 start-page: 538 year: 1981 ident: BF03038915_CR28 publication-title: Cancer doi: 10.1002/1097-0142(19810715)48:1+<538::AID-CNCR2820481317>3.0.CO;2-P contributor: fullname: C. C. Wang – volume: 104 start-page: 485 year: 1969 ident: BF03038915_CR18 publication-title: Amer. J. Obstet. Gynec. doi: 10.1016/S0002-9378(16)34236-3 contributor: fullname: B. M. Peckham – volume: 31 start-page: 28 issue: Suppl. 1 year: 1994 ident: BF03038915_CR1 publication-title: Radiother. Oncol. doi: 10.1016/0167-8140(94)91126-6 contributor: fullname: A. Arican – volume: 25 start-page: 733 year: 1990 ident: BF03038915_CR5 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(93)90022-N contributor: fullname: A. Eisbruch – volume: 21 start-page: 195 issue: Suppl. 1 year: 1991 ident: BF03038915_CR2 publication-title: Int. J. Radiat. Oncol. Biol. Phys. contributor: fullname: B. Corn – volume: 13 start-page: 1025 year: 1997 ident: BF03038915_CR21 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(87)90041-1 contributor: fullname: H. Pourquier – volume: 161 start-page: 343 year: 1985 ident: BF03038915_CR25 publication-title: Strahlentherapie contributor: fullname: T. Teschima – volume: 63 start-page: 8 year: 1992 ident: BF03038915_CR7 publication-title: Gin. Pol. contributor: fullname: A. Górny – volume: 9 start-page: 367 year: 1983 ident: BF03038915_CR9 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(83)90298-5 contributor: fullname: A. D. Hamberger – volume: 60 start-page: 921 year: 1966 ident: BF03038915_CR15 publication-title: Radiology doi: 10.1148/86.5.921 contributor: fullname: R. R. Million – volume: 29 start-page: 1 year: 1988 ident: BF03038915_CR24 publication-title: Gynec. Oncol. doi: 10.1016/0090-8258(88)90140-0 contributor: fullname: J. A. Stryker – volume: 56 start-page: 409 year: 1983 ident: BF03038915_CR29 publication-title: Brit. J. Radiol. doi: 10.1259/0007-1285-56-666-409 contributor: fullname: J. M. Wilkinson – volume-title: Dose and volume specification for reporting intracavitary therapy in gynecology year: 1985 ident: BF03038915_CR10 contributor: fullname: ICRU Report 38 – volume: 8 start-page: 1887 year: 1982 ident: BF03038915_CR22 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(82)90446-1 contributor: fullname: H. Pourquier – volume: 60 start-page: 481 year: 1987 ident: BF03038915_CR11 publication-title: Brit. J. Radiol. doi: 10.1259/0007-1285-60-713-481 contributor: fullname: D. A. Jones – volume: 62 start-page: 362 year: 1989 ident: BF03038915_CR30 publication-title: Brit. J. Radiol. doi: 10.1259/0007-1285-62-736-362 contributor: fullname: J. M. Wilkinson – volume-title: Annual Report on the results of treatment in gynecological cancer year: 1990 ident: BF03038915_CR19 – volume: 7 start-page: 999 year: 1981 ident: BF03038915_CR27 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(81)90150-4 contributor: fullname: A. Unal – volume: 36 start-page: 131 year: 1985 ident: BF03038915_CR23 publication-title: Clin. Radiol. doi: 10.1016/S0009-9260(85)80095-7 contributor: fullname: E. Sherrah-Davies – volume: 12 start-page: 37 year: 1986 ident: BF03038915_CR17 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(86)90413-X contributor: fullname: C. G. Orton – volume: 7 start-page: 653 year: 1981 ident: BF03038915_CR4 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(81)90381-3 contributor: fullname: D. E. Cunningham – volume: 27 start-page: 725 year: 1993 ident: BF03038915_CR8 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(93)90402-H contributor: fullname: P. W. Grigsby – volume: 8 start-page: 321 year: 1987 ident: BF03038915_CR3 publication-title: Radiother. Oncol. doi: 10.1016/S0167-8140(87)80182-2 contributor: fullname: J. M. Crook – volume: 13 start-page: 1183 year: 1987 ident: BF03038915_CR6 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(87)90193-3 contributor: fullname: B. A. Esche |
SSID | ssj0016494 |
Score | 1.5328166 |
Snippet | Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications... AimAlthough the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment... AIMAlthough the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 323 |
SubjectTerms | Anesthesia Biological and medical sciences Bladder Brachytherapy - instrumentation Cancer Cervical cancer Female Humans Linear Models Medical sciences Multivariate analysis Optimization Organs Pellets Radiation Dosage Radiation therapy Radiotherapy Dosage Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Rectum Rectum - radiation effects Retrospective Studies Technology. Biomaterials. Equipments. Material. Instrumentation Urinary Bladder - radiation effects Uterine Cervical Neoplasms - radiotherapy |
Title | Influence of brachytherapy applicators geometry on dose distribution in cervical cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9209530 https://www.proquest.com/docview/821763140 https://search.proquest.com/docview/79112759 |
Volume | 173 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fa9swEBZZC2Mwyn6VeV03wfYWPGzLtuzHsKSky9YN0rH0ydiSvAZTu8TJQ__73lmWHcM2toe9hCAHJei-nL67k74j5L3EYk_mZXbMBbP91HXtFG8s5xFjzM9hx-Z4OXm-5BeraDrzZ6OR6ZrRj_1XS8MY2Bpvzv6DtbtJYQDeg83hFawOr39l93PTdQRpIITC4vpO37G6G5tiNfbX-amqG7XF-no5lnhmXaKCbtv8CpMgonEiqB6CuNjsk1hUtL3G3aqZd62wl-74a1k0frQDylKVxa62F1Wp8iIdXHpYVBl24C7SQTL1E_B4dTMsValNsdaObNHnJ7S2a7ifnzD5STx8jSWR7v6MTmfy2OauFm__oLQLBopkA29dDXy07nfSgjH8pe93-hPtWHwN-h3OVPXnk2XybXqWfD6_WAyfNhs6UKUQwsMYdQkOPXBc4DcPJ6urq2lXlwr9WKvFt797KHjbfvGA4jy-TWswVq7bpPw-jmn4zOUTctQGInSiEfSUjFT5jDz80h61eE5-dECiVU4HQKJ7QKIGSLQqKQKJ7gOJrktqgEQ1kF6Q72ezy49zu-3CYQsvYFsbGLrw3TSSLJI5F34euyoUkRME0kmZiF3GgQcqxdKIcwkEGQYjBWGQDKJQiJAdk4MSoPaSUCUDoJyRyLgK_IzBCnt-IFHEjvs5EE2LvDMLl9xqsZXEyGr3y2uR08Gadh_1uIPRskVOzBon7R-zTiIIvUPm-o5F3nZPwZNieSwtVbWrEw77vseD2CLH2jDdxLGHqozOqz9OfEIe9fB_TQ62m506JQ9quXvTougeqw-YxA |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+brachytherapy+applicators+geometry+on+dose+distribution+in+cervical+cancer&rft.jtitle=Strahlentherapie+und+Onkologie&rft.au=Senkus-Konefka%2C+E&rft.au=Kobierska%2C+A&rft.au=Jassem%2C+J&rft.au=Serkies%2C+K&rft.date=1997-06-01&rft.pub=Springer+Nature+B.V&rft.issn=0179-7158&rft.eissn=1439-099X&rft.volume=173&rft.issue=6&rft_id=info:doi/10.1007%2FBF03038915&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2226114921 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-7158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-7158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-7158&client=summon |